Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Marie Momot
GTL001, a Bivalent Therapeutic Vaccine Against Human Papillomavirus 16 and 18, Induces Antigen-Specific CD8+ T Cell Responses Leading to Tumor Regression
PLoS ONE
Multidisciplinary
Related publications
Human HSP70 and Modified HPV16 E7 Fusion DNA Vaccine Induces Enhanced Specific CD8+ T Cell Responses and Anti-Tumor Effects
Oncology Reports
Medicine
Cancer Research
Oncology
Intravaginal TLR Agonists Increase Local Vaccine-Specific CD8 T Cells and Human Papillomavirus-Associated Genital-Tumor Regression in Mice
Mucosal Immunology
Allergy
Immunology
GTL001, a Therapeutic Vaccine for Women Infected With Human Papillomavirus 16 or 18 and Normal Cervical Cytology: Results of a Phase I Clinical Trial
Clinical Cancer Research
Cancer Research
Oncology
Persistent Antigen at Vaccination Sites Induces Tumor-Specific CD8+ T Cell Sequestration, Dysfunction and Deletion
Nature Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Risk of Miscarriage With Bivalent Vaccine Against Human Papillomavirus (HPV) Types 16 and 18: Pooled Analysis of Two Randomised Controlled Trials
BMJ
MHC-based Detection of Antigen-Specific CD8+ T Cell Responses
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
Rift Valley Fever Virus Vaccination Induces Long-Lived, Antigen-Specific Human T Cell Responses
npj Vaccines
Infectious Diseases
Immunology
Pharmacology
Peptide Vaccine Formulation Controls the Duration of Antigen Presentation and Magnitude of Tumor-Specific CD8+T Cell Response
Journal of Immunology
Allergy
Immunology
Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine
Drugs
Pharmacology
